{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:46:46Z","timestamp":1789681606975,"version":"4.0.1"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"am","delay-in-days":315,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013317","name":"Shanxi Provincial Key Research and Development Project","doi-asserted-by":"publisher","award":["2023-ZDISF-41"],"award-info":[{"award-number":["2023-ZDISF-41"]}],"id":[{"id":"10.13039\/501100013317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.clim.2024.110264","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T16:15:27Z","timestamp":1717172127000},"page":"110264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["The immunomodulatory of interleukin-33 in rheumatoid arthritis: A systematic review"],"prefix":"10.1016","volume":"265","author":[{"given":"Renli","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengfan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haomiao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clim.2024.110264_bb0005","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMra2103726","article-title":"Rheumatoid arthritis - common origins, divergent mechanisms","volume":"388","author":"Gravallese","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"7987","key":"10.1016\/j.clim.2024.110264_bb0010","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-023-06708-y","article-title":"Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes","volume":"623","author":"Zhang","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.clim.2024.110264_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10787-023-01221-0","article-title":"Rheumatoid arthritis","volume":"32","author":"Buchanan","year":"2024","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.clim.2024.110264_bb0020","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.freeradbiomed.2023.07.016","article-title":"Nrf2 activation improves experimental rheumatoid arthritis","volume":"207","author":"Zhang","year":"2023","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.clim.2024.110264_bb0025","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jaad.2023.09.046","article-title":"Associations between rheumatoid arthritis and skin cancer: a bidirectional two-sample Mendelian randomization study","volume":"90","author":"Yu","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"issue":"13","key":"10.1016\/j.clim.2024.110264_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241311060","article-title":"The pathogenesis of rheumatoid arthritis breakthroughs in molecular mechanisms 1 and 2","volume":"24","author":"Nanke","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2024.110264_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1160397","article-title":"Identifying shared genetic loci and common risk genes of rheumatoid arthritis associated with three autoimmune diseases based on large-scale cross-trait genome-wide association studies","volume":"14","author":"Wen","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2024.110264_bb0040","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.immuni.2021.12.001","article-title":"Disruption of the IL-33-ST2-AKT signaling axis impairs neurodevelopment by inhibiting microglial metabolic adaptation and phagocytic function","volume":"55","author":"He","year":"2022","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.clim.2024.110264_bb0045","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/hep.32744","article-title":"Interleukin-33 facilitates liver regeneration through serotonin-involved gut-liver axis","volume":"77","author":"Wen","year":"2023","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"9","key":"10.1016\/j.clim.2024.110264_bb0050","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1161\/CIRCULATIONAHA.122.063014","article-title":"Interleukin-33 mediates cardiomyopathy after acute kidney injury by signaling to cardiomyocytes","volume":"147","author":"Florens","year":"2023","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.clim.2024.110264_bb0055","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02210-2022","article-title":"Oxidised IL-33 drives COPD epithelial pathogenesis via ST2-independent RAGE\/EGFR signalling complex","volume":"62","author":"Strickson","year":"2023","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.clim.2024.110264_bb0060","series-title":"Rheumatology (Oxford, England)","article-title":"Serum alarmins and the risk of incident interstitial lung disease in rheumatoid arthritis","author":"Poole","year":"2023"},{"issue":"48","key":"10.1016\/j.clim.2024.110264_bb0065","article-title":"A targeted exosome therapeutic confers both CfDNA scavenging and macrophage polarization for ameliorating rheumatoid arthritis","volume":"35","author":"Wang","year":"2023","journal-title":"Adv. mat. (Deerfield Beach, Fla)"},{"key":"10.1016\/j.clim.2024.110264_bb0070","article-title":"IL-33 potentiates histaminergic itch","author":"Trier","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2024.110264_bb0075","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/imr.12619","article-title":"Interleukin-33 (IL-33): a nuclear cytokine from the IL-1 family","volume":"281","author":"Cayrol","year":"2018","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.clim.2024.110264_bb0080","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.immuni.2023.01.029","article-title":"The alarmin interleukin-33 promotes the expansion and preserves the stemness of Tcf-1(+) CD8(+) T cells in chronic viral infection","volume":"56","author":"Marx","year":"2023","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.clim.2024.110264_bb0085","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/TP.0000000000004447","article-title":"The reparative roles of IL-33","volume":"107","author":"Bou Saba","year":"2023","journal-title":"Transplantation"},{"issue":"34","key":"10.1016\/j.clim.2024.110264_bb0090","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.add7399","article-title":"Amphiregulin couples IL1RL1(+) regulatory T cells and cancer-associated fibroblasts to impede antitumor immunity","volume":"9","author":"Sun","year":"2023","journal-title":"Sci. Adv."},{"issue":"10","key":"10.1016\/j.clim.2024.110264_bb0095","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41419-023-06182-4","article-title":"Macrophages originated IL-33\/ST2 inhibits ferroptosis in endometriosis via the ATF3\/SLC7A11 axis","volume":"14","author":"Wu","year":"2023","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.clim.2024.110264_bb0100","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1093\/rheumatology\/keac640","article-title":"Rheumatoid arthritis macrophages are primed for inflammation and display bioenergetic and functional alterations","volume":"62","author":"Hanlon","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.clim.2024.110264_bb0105","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13075-018-1628-6","article-title":"Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis","volume":"20","author":"Rivi\u00e8re","year":"2018","journal-title":"Arthritis Res. Ther."},{"issue":"82","key":"10.1016\/j.clim.2024.110264_bb0110","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add8945","article-title":"Identification of a broadly fibrogenic macrophage subset induced by type 3 inflammation","volume":"8","author":"Fabre","year":"2023","journal-title":"Sci. immunology"},{"issue":"5","key":"10.1016\/j.clim.2024.110264_bb0115","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/gutjnl-2022-327183","article-title":"MCPIP1 restrains mucosal inflammation by orchestrating the intestinal monocyte to macrophage maturation via an ATF3-AP1S2 axis","volume":"72","author":"Lu","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.clim.2024.110264_bb0120","doi-asserted-by":"crossref","unstructured":"Li L, Cao J, Li S, Cui T, Ni J, Zhang H, Zhu Y, Mao J, Gao X, Midgley AC et al: M2 Macrophage-Derived sEV Regulate pro-Inflammatory CCR2(+) Macrophage Subpopulations to Favor Post-AMI Cardiac Repair. Advanced Science (Weinheim, Baden-Wurttemberg, Germany) 2023, 10(14):e2202964.","DOI":"10.1002\/advs.202202964"},{"issue":"12","key":"10.1016\/j.clim.2024.110264_bb0125","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1001\/jama.2022.0786","article-title":"What is rheumatoid arthritis?","volume":"327","author":"Smith","year":"2022","journal-title":"Jama"},{"issue":"16","key":"10.1016\/j.clim.2024.110264_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23168857","article-title":"Inhibition of TREM-2 markedly suppresses joint inflammation and damage in experimental arthritis","volume":"23","author":"Sigalov","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2024.110264_bb0135","article-title":"Emodin promotes the recovery of rheumatoid arthritis by regulating the crosstalk between macrophage subsets and synovial fibroblast subsets","author":"Cheng","year":"2024","journal-title":"Animal models experimental medicine"},{"issue":"5","key":"10.1016\/j.clim.2024.110264_bb0140","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s10753-023-01855-w","article-title":"Bavachinin ameliorates rheumatoid arthritis inflammation via PPARG\/PI3K\/AKT signaling pathway","volume":"46","author":"Deng","year":"2023","journal-title":"Inflammation"},{"issue":"9","key":"10.1016\/j.clim.2024.110264_bb0145","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1136\/ard.2009.122655","article-title":"IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy","volume":"69","author":"Verri","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2024.110264_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.631603","article-title":"IL-33 gene polymorphisms as potential biomarkers of disease susceptibility and response to TNF inhibitors in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis patients","volume":"12","author":"Iwaszko","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.110264_bb0155","article-title":"GM-CSF expression and macrophage polarization in joints of undifferentiated arthritis patients evolving to rheumatoid arthritis or psoriatic arthritis","volume":"11","author":"Fuentelsaz-Romero","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.110264_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175466","article-title":"Activation of angiotensin II type 2 receptor attenuates lung injury of collagen-induced arthritis by alleviating endothelial cell injury and promoting Ly6C(lo) monocyte transition","volume":"941","author":"Xu","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.clim.2024.110264_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.867260","article-title":"The role of M1\/M2 macrophage polarization in rheumatoid arthritis synovitis","volume":"13","author":"Cutolo","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.110264_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104603","article-title":"Magnesium increases numbers of Foxp3+ Treg cells and reduces arthritis severity and joint damage in an IL-10-dependent manner mediated by the intestinal microbiome","volume":"92","author":"Laragione","year":"2023","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.clim.2024.110264_bb0175","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/art.39574","article-title":"Brief report: Proatherogenic cytokine microenvironment in the aortic adventitia of patients with rheumatoid arthritis","volume":"68","author":"Ahmed","year":"2016","journal-title":"Arthritis & rheumatology (Hoboken, NJ)"},{"key":"10.1016\/j.clim.2024.110264_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1037983","article-title":"An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis","volume":"13","author":"Vugler","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.clim.2024.110264_bb0185","article-title":"Th2 and eosinophil responses suppress inflammatory arthritis","volume":"7","author":"Chen","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2024.110264_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104842","article-title":"Glucocorticoid-induced leucine zipper modulates macrophage polarization and apoptotic cell clearance","volume":"158","author":"Vago","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.clim.2024.110264_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1178172","article-title":"Targeting the chemokine receptor CXCR4 with histamine analog to reduce inflammation in juvenile arthritis","volume":"14","author":"Bekaddour","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.110264_bb0200","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2147\/DDDT.S391606","article-title":"Anti-arthritic effect of Edaravone against complete Freund adjuvant induced arthritis via osteoclast differentiation and HIF-1\u03b1-VEGF-ANG-1 Axis","volume":"17","author":"Liu","year":"2023","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.clim.2024.110264_bb0205","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.actbio.2022.08.054","article-title":"An ROS-responsive artesunate prodrug nanosystem co-delivers dexamethasone for rheumatoid arthritis treatment through the HIF-1\u03b1\/NF-\u03baB cascade regulation of ROS scavenging and macrophage repolarization","volume":"152","author":"Li","year":"2022","journal-title":"Acta Biomater."},{"issue":"8","key":"10.1016\/j.clim.2024.110264_bb0210","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23116","article-title":"The protective effects of NE 52-QQ57 against interleukin-33-induced inflammatory response in activated synovial mast cells","volume":"36","author":"Li","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.clim.2024.110264_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110559","article-title":"Hypoxia induces the production of epithelial-derived cytokines in eosinophilic chronic rhinosinusitis with nasal polyps","volume":"121","author":"Zhang","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.clim.2024.110264_bb0220","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13293-023-00495-x","article-title":"Sex differences in the percentage of IRF5 positive B cells are associated with higher production of TNF-\u03b1 in women in response to TLR9 in humans","volume":"14","author":"Beisel","year":"2023","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.clim.2024.110264_bb0225","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.intimp.2017.08.001","article-title":"MiR-let-7a regulates anti-citrullinated protein antibody-induced macrophage activation and correlates with the development of experimental rheumatoid arthritis","volume":"51","author":"Zhu","year":"2017","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.clim.2024.110264_bb0230","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s10875-009-9360-2","article-title":"Interleukin-32gamma enhances the production of IL-6 and IL-8 in fibroblast-like synoviocytes via Erk1\/2 activation","volume":"30","author":"Kim","year":"2010","journal-title":"J. Clin. Immunol."},{"issue":"10","key":"10.1016\/j.clim.2024.110264_bb0235","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/s41423-022-00913-x","article-title":"Extracellular sulfatase-2 is overexpressed in rheumatoid arthritis and mediates the TNF-\u03b1-induced inflammatory activation of synovial fibroblasts","volume":"19","author":"Siegel","year":"2022","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2024.110264_bb0240","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12931-022-02085-8","article-title":"Increased susceptibility to organic dust exposure-induced inflammatory lung disease with enhanced rheumatoid arthritis-associated autoantigen expression in HLA-DR4 transgenic mice","volume":"23","author":"Poole","year":"2022","journal-title":"Respir. Res."},{"issue":"3","key":"10.1016\/j.clim.2024.110264_bb0245","doi-asserted-by":"crossref","first-page":"L239","DOI":"10.1152\/ajplung.00221.2023","article-title":"Combined repetitive inhalant endotoxin and collagen-induced arthritis drive inflammatory lung disease and arthritis severity in a testosterone-dependent manner","volume":"326","author":"Poole","year":"2024","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.clim.2024.110264_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111525","article-title":"Extracellular CIRP induces abnormal activation of fibroblast-like synoviocytes from patients with RA via the TLR4-mediated HDAC3 pathways","volume":"128","author":"Yao","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.clim.2024.110264_bb0255","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116279119","article-title":"Reciprocal regulation of IL-33 receptor-mediated inflammatory response and pulmonary fibrosis by TRAF6 and USP38","volume":"119","author":"Yi","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.clim.2024.110264_bb0260","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev-immunol-101921-045939","article-title":"TGF-\u03b2 regulation of T cells","volume":"41","author":"Chen","year":"2023","journal-title":"Annu. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.clim.2024.110264_bb0265","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s41590-021-01008-x","article-title":"Restoring control over autoimmunity by inducing Foxp3","volume":"22","author":"Ono","year":"2021","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.clim.2024.110264_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119227","article-title":"The IL-33\/IL-31 Axis in allergic and immune-mediated diseases","volume":"24","author":"Murdaca","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.clim.2024.110264_bb0275","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1210\/clinem\/dgab526","article-title":"Analysis of expression of different histone deacetylases in autoimmune thyroid disease","volume":"106","author":"Sacrist\u00e1n-G\u00f3mez","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.clim.2024.110264_bb0280","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.jaci.2021.08.020","article-title":"The STE20 kinase TAOK3 controls the development of house dust mite-induced asthma in mice","volume":"149","author":"Maes","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2024.110264_bb0285","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13075-021-02491-1","article-title":"Regulation of osteoclastogenesis by mast cell in rheumatoid arthritis","volume":"23","author":"Kim","year":"2021","journal-title":"Arthritis Res. Ther."},{"issue":"9","key":"10.1016\/j.clim.2024.110264_bb0290","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.immuni.2022.08.007","article-title":"Induction of a colitogenic phenotype in Th1-like cells depends on interleukin-23 receptor signaling","volume":"55","author":"Pawlak","year":"2022","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.clim.2024.110264_bb0295","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and Cancer risk with Tofacitinib in rheumatoid arthritis","volume":"386","author":"Ytterberg","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"40","key":"10.1016\/j.clim.2024.110264_bb0300","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2215421120","article-title":"Externalized histones fuel pulmonary fibrosis via a platelet-macrophage circuit of TGF\u03b21 and IL-27","volume":"120","author":"Riehl","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.clim.2024.110264_bb0305","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.mucimm.2023.09.006","article-title":"The IL-17A-neutrophil axis promotes epithelial cell IL-33 production during nematode lung migration","volume":"16","author":"Ajendra","year":"2023","journal-title":"Mucosal Immunol."},{"issue":"1","key":"10.1016\/j.clim.2024.110264_bb0310","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1186\/s12967-023-04474-z","article-title":"Identification of potential drug targets for rheumatoid arthritis from genetic insights: a Mendelian randomization study","volume":"21","author":"Cao","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.clim.2024.110264_bb0315","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/985301","article-title":"Increased IL-33 in synovial fluid and paired serum is associated with disease activity and autoantibodies in rheumatoid arthritis","volume":"2013","author":"Tang","year":"2013","journal-title":"Clin. Dev. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2024.110264_bb0320","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/annrheumdis-2020-218902","article-title":"Regulatory eosinophils induce the resolution of experimental arthritis and appear in remission state of human rheumatoid arthritis","volume":"80","author":"Andreev","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.clim.2024.110264_bb0325","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.3899\/jrheum.100184","article-title":"Elevated serum interleukin 33 is associated with autoantibody production in patients with rheumatoid arthritis","volume":"37","author":"Mu","year":"2010","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.clim.2024.110264_bb0330","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/s10165-011-0480-1","article-title":"Involvement of IL-33 in the pathogenesis of rheumatoid arthritis: the effect of etanercept on the serum levels of IL-33","volume":"22","author":"Kageyama","year":"2012","journal-title":"Mod. Rheumatol."},{"issue":"1","key":"10.1016\/j.clim.2024.110264_bb0335","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cyto.2011.12.010","article-title":"Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis","volume":"58","author":"Xiangyang","year":"2012","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.clim.2024.110264_bb0340","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00296-011-1854-6","article-title":"Sustained elevation of interleukin-33 in sera and synovial fluids from patients with rheumatoid arthritis non-responsive to anti-tumor necrosis factor: possible association with persistent IL-1\u03b2 signaling and a poor clinical response","volume":"32","author":"Matsuyama","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.clim.2024.110264_bb0345","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-1-0716-1566-9_10","article-title":"Meta-analysis of proportions","volume":"2345","author":"Schwarzer","year":"2022","journal-title":"Methods mol. biol. (Clifton, NJ)"},{"issue":"1","key":"10.1016\/j.clim.2024.110264_bb0350","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s41232-023-00264-8","article-title":"A lesion-selective albumin-CTLA4Ig as a safe and effective treatment for collagen-induced arthritis","volume":"43","author":"Jiang","year":"2023","journal-title":"Inflammation regeneration"},{"issue":"3","key":"10.1016\/j.clim.2024.110264_bb0355","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11030974","article-title":"Subclinical carotid atherosclerosis in patients with rheumatoid arthritis at low cardiovascular risk","volume":"11","author":"Gerasimova","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.clim.2024.110264_bb0360","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s13075-016-1190-z","article-title":"Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis","volume":"18","author":"Sellam","year":"2016","journal-title":"Arthritis Res. Ther."},{"issue":"4","key":"10.1016\/j.clim.2024.110264_bb0365","doi-asserted-by":"crossref","first-page":"389","DOI":"10.5606\/ArchRheumatol.2018.6753","article-title":"Effects of tocilizumab therapy on serum Interleukin-33 and Interleukin-6 levels in patients with rheumatoid arthritis","volume":"33","author":"Choi","year":"2018","journal-title":"Arch. rheumatol."},{"issue":"1","key":"10.1016\/j.clim.2024.110264_bb0370","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s13075-016-1190-z","article-title":"Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis","volume":"18","author":"Sellam","year":"2016","journal-title":"Arthritis Res. Ther."},{"issue":"11","key":"10.1016\/j.clim.2024.110264_bb0375","doi-asserted-by":"crossref","first-page":"e648","DOI":"10.1016\/S2665-9913(23)00241-2","article-title":"Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials","volume":"5","author":"Rivellese","year":"2023","journal-title":"Lancet Rheumatol."},{"issue":"4","key":"10.1016\/j.clim.2024.110264_bb0380","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003400","article-title":"COVID-19 vaccine in immunosuppressed adults with autoimmune rheumatic diseases (COVIAAD): safety, immunogenicity and antibody persistence at 12 months following Moderna Spikevax primary series","volume":"9","author":"Colmegna","year":"2023","journal-title":"RMD Open"},{"issue":"4","key":"10.1016\/j.clim.2024.110264_bb0385","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.chest.2022.11.035","article-title":"Treatment outcomes for rheumatoid arthritis-associated interstitial lung disease: a real-world, multisite study of the impact of immunosuppression on pulmonary function trajectory","volume":"163","author":"Matson","year":"2023","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.clim.2024.110264_bb0390","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/annrheumdis-2021-220973","article-title":"EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis","volume":"81","author":"Nagy","year":"2022","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.clim.2024.110264_bb0395","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41584-020-00541-7","article-title":"Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis","volume":"17","author":"Buch","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.clim.2024.110264_bb0400","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002842","article-title":"Difficult-to-treat rheumatoid arthritis (D2T RA): clinical issues at early stages of disease","volume":"9","author":"Leon","year":"2023","journal-title":"RMD Open"},{"issue":"12","key":"10.1016\/j.clim.2024.110264_bb0405","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.734","article-title":"Etanercept alleviates psoriasis by reducing the Th17\/Treg ratio and promoting M2 polarization of macrophages","volume":"10","author":"Li","year":"2022","journal-title":"Immunity, inflammation disease"},{"key":"10.1016\/j.clim.2024.110264_bb0410","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2016.03.028","article-title":"Modulation of human monocyte\/macrophage activity by tocilizumab, abatacept and etanercept: an in vitro study","volume":"780","author":"Obeng","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.clim.2024.110264_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174564","article-title":"Tofacitinib enhances interferon-\u03b3-induced expression of major histocompatibility complex class II in macrophages","volume":"915","author":"Mizuno","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.clim.2024.110264_bb0420","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/exd.14059","article-title":"The Janus kinase inhibitor tofacitinib impacts human dendritic cell differentiation and favours M1 macrophage development","volume":"29","author":"Stalder","year":"2020","journal-title":"Exp. Dermatol."},{"issue":"18","key":"10.1016\/j.clim.2024.110264_bb0425","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1182\/blood.2021014267","article-title":"The SUMOylation inhibitor subasumstat potentiates rituximab activity by IFN1-dependent macrophage and NK cell stimulation","volume":"139","author":"Nakamura","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clim.2024.110264_bb0430","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/annrheumdis-2011-200348","article-title":"Abatacept modulates proinflammatory macrophage responses upon cytokine-activated T cell and Toll-like receptor ligand stimulation","volume":"71","author":"Wenink","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.clim.2024.110264_bb0435","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/039463201002300211","article-title":"Divergent effects of infliximab and anakinra therapies on macrophage phenotype from patients with refractory rheumatoid arthritis","volume":"23","author":"Pham","year":"2010","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"9","key":"10.1016\/j.clim.2024.110264_bb0440","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1136\/ard.2010.146225","article-title":"Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-\u03b1, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human study","volume":"70","author":"Burmester","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.clim.2024.110264_bb0445","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1136\/annrheumdis-2012-202450","article-title":"Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis","volume":"72","author":"Burmester","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.clim.2024.110264_bb0450","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/annrheumdis-2013-204816","article-title":"MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib\/IIa randomised, double-blind, placebo-controlled, dose-escalation trial","volume":"74","author":"Behrens","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"40","key":"10.1016\/j.clim.2024.110264_bb0455","doi-asserted-by":"crossref","first-page":"65968","DOI":"10.18632\/oncotarget.11782","article-title":"Ibrutinib modifies the function of monocyte\/macrophage population in chronic lymphocytic leukemia","volume":"7","author":"Fiorcari","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.clim.2024.110264_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115560","article-title":"Dynamic polarization shifting from M1 to M2 macrophages in reduced osteonecrosis of the jaw-like lesions by cessation of anti-RANKL antibody in mice","volume":"141","author":"Tamaki","year":"2020","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.clim.2024.110264_bb0465","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4062\/biomolther.2019.153","article-title":"PBT-6, a novel PI3KC2\u03b3 inhibitor in rheumatoid arthritis","volume":"28","author":"Kim","year":"2020","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.clim.2024.110264_bb0470","doi-asserted-by":"crossref","unstructured":"Qiu C, Chan JTW, Zhang DW, Wong IN, Zeng Y, Law BYK, Mok SWF, De Seabra Rodrigues Dias IR, Liu W, Liu L et al: The potential development of drug resistance in rheumatoid arthritis patients identified with p53 mutations. Genes & diseas. 2023, 10(6):2252\u20132255.","DOI":"10.1016\/j.gendis.2023.02.007"},{"key":"10.1016\/j.clim.2024.110264_bb0475","article-title":"Inhibition of murine colorectal cancer metastasis by targeting M2-TAM through STAT3\/NF-kB\/AKT signaling using macrophage 1-derived extracellular vesicles loaded with oxaliplatin, retinoic acid, and Libidibia ferrea","volume":"168","author":"de Carvalho","year":"2023","journal-title":"Biomed. & pharmacother = Biomed & pharmacotherapie"},{"issue":"1","key":"10.1016\/j.clim.2024.110264_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2023.152767","article-title":"Vitexin along with verapamil downregulates efflux pump P-glycoprotein in macrophages and potentiate M1 to M2 switching via TLR4-NF-\u03baB-TNFR2 pathway in lipopolysaccharide treated mice","volume":"229","author":"Kundu","year":"2024","journal-title":"Immunobiology"},{"issue":"3","key":"10.1016\/j.clim.2024.110264_bb0485","first-page":"557","article-title":"Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension","volume":"47","author":"Elmarakby","year":"2006"},{"issue":"17","key":"10.1016\/j.clim.2024.110264_bb0490","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179718","article-title":"Interleukin-23 mediates Osteoclastogenesis in collagen-induced arthritis by modulating MicroRNA-223","volume":"23","author":"Chen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.clim.2024.110264_bb0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143153","article-title":"Protective rRole of the interleukin 33 rs3939286 gene polymorphism in the development of subclinical atherosclerosis in rheumatoid arthritis patients","volume":"10","author":"L\u00f3pez-Mej\u00edas","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.clim.2024.110264_bb0500","doi-asserted-by":"crossref","first-page":"R105","DOI":"10.1186\/ar4554","article-title":"Genetic variant in IL33 is associated with susceptibility to rheumatoid arthritis","volume":"16","author":"Li","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"4","key":"10.1016\/j.clim.2024.110264_bb0505","first-page":"233","article-title":"Long-term treatment of patients affected by systemic sclerosis with cyclosporin a","volume":"16","author":"Basso","year":"2001","journal-title":"Annali italiani di medicina interna\u202f: organo ufficiale della Societa italiana di medicina interna"},{"issue":"7","key":"10.1016\/j.clim.2024.110264_bb0510","doi-asserted-by":"crossref","DOI":"10.3390\/biom13071091","article-title":"Pro-calcifying role of enzymatically modified LDL (eLDL) in aortic valve sclerosis via induction of IL-6 and IL-33","volume":"13","author":"Witz","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.clim.2024.110264_bb0515","article-title":"IL-33\/ST2 immunobiology in coronary artery disease: a systematic review and meta-analysis","volume":"9","author":"Liu","year":"2022","journal-title":"Front. cardiovasc. med."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661624003735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661624003735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T08:08:38Z","timestamp":1750147718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661624003735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":103,"alternative-id":["S1521661624003735"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2024.110264","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The immunomodulatory of interleukin-33 in rheumatoid arthritis: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2024.110264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110264"}}